Skip to main content
NCBI home page
PLOS One logoLink to PLOS One
. 2020 Mar 25;15(3):e0230414. doi: 10.1371/journal.pone.0230414

Onset of brain injury in infants with prenatally diagnosed congenital heart disease

Mirthe J Mebius 1,*, Catherina M Bilardo 2, Martin C J Kneyber 3,4, Marco Modestini 5, Tjark Ebels 6, Rolf M F Berger 7, Arend F Bos 1, Elisabeth M W Kooi 1
Editor: Emma Duerden8
PMCID: PMC7094875  PMID: 32210445

Abstract

Background

The exact onset of brain injury in infants with congenital heart disease (CHD) is unknown. Our aim was, therefore, to assess the association between prenatal Doppler flow patterns, postnatal cerebral oxygenation and short-term neurological outcome.

Methods

Prenatally, we measured pulsatility indices of the middle cerebral (MCA-PI) and umbilical artery (UA-PI) and calculated cerebroplacental ratio (CPR). After birth, cerebral oxygen saturation (rcSO2) and fractional tissue oxygen extraction (FTOE) were assessed during the first 3 days after birth, and during and for 24 hours after every surgical procedure within the first 3 months after birth. Neurological outcome was determined preoperatively and at 3 months of age by assessing general movements and calculating the Motor Optimality Score (MOS).

Results

Thirty-six infants were included. MOS at 3 months was associated with MCA-PI (rho 0.41, P = 0.04), UA-PI (rho -0.39, P = 0.047, and CPR (rho 0.50, P = 0.01). Infants with abnormal MOS had lower MCA-PI (P = 0.02) and CPR (P = 0.01) and higher UA-PI at the last measurement (P = 0.03) before birth. In infants with abnormal MOS, rcSO2 tended to be lower during the first 3 days after birth, and FTOE was significantly higher on the second day after birth (P = 0.04). Intraoperative and postoperative rcSO2 and FTOE were not associated with short-term neurological outcome.

Conclusion

In infants with prenatally diagnosed CHD, the prenatal period may play an important role in developmental outcome. Additional research is needed to clarify the relationship between preoperative, intra-operative and postoperative cerebral oxygenation and developmental outcome in infants with prenatally diagnosed CHD.

Introduction

Up to 50% of infants with congenital heart disease (CHD) have neurodevelopmental impairments later in life [1]. As a consequence, many adults with CHD experience psychosocial and cognitive challenges that could affect quality of life [2,3]. Increasing evidence suggests that neurodevelopmental impairments in infants with CHD may result from insults occurring from as early as the second trimester.

Prenatally, circulatory alterations and impaired brain maturation have been frequently observed [4]. Fetuses with CHD have increased cerebral blood flow [5,6], decreased cerebral vascular resistance [5–9], smaller head circumference [7,8,10], lower total brain weight [11], impairments in sulcation [12,13], altered cerebral metabolism [13,14], and abnormalities on MRI that are in accordance with impaired brain maturation such as ventriculomegaly and increased extra-axial cerebrospinal fluid spaces [15,16].

After birth, many of the prenatal findings, such as a smaller head circumference, lower total brain volumes, and an altered cerebral metabolism persist [4,17–21]. Furthermore, in comparison with healthy newborns, infants with CHD have lower cerebral oxygen saturation [22,23], more neurobehavioral abnormalities [24], increased epileptic activity [25,26] and up to 53% show brain abnormalities on MRI prior to surgery [27–29]. The most commonly observed abnormalities include white matter injury, and stroke [27–29].

Surgical procedures and the postoperative period pose an additional threat to the young brain. Ischemia and reperfusion injury, hypothermia, inflammatory and immune responses, altered cerebral blood flow regulation and decreased cardiac output might all contribute to brain injury during and after surgery [30,31]. New brain abnormalities on MRI after cardiac surgery are reported in up to 78% of infants with CHD [32,33].

Currently, it is still unknown which period is the most threatening for the young developing brain in infants with CHD. To date, no study has assessed cerebral abnormalities and its relation with neurological outcome from before birth to the postoperative period in these infants. Our aim was, therefore, to perform a longitudinal assessment of prenatal Doppler flow patterns and postnatal, intraoperative and postoperative cerebral oxygen saturation and extraction in relation to short-term neurological outcome in infants with CHD that were admitted to the intensive care (ICU) immediately after birth.

Methods

Study population

A prospective observational cohort study (registration number: NTR5523) was conducted at the fetal medicine unit, the NICU, congenital heart center and pediatric intensive care unit of the University Medical Center Groningen. Between May 2014 and August 2016, all fetuses with isolated CHD expected to require ICU admission immediately after birth were prenatally enrolled when parental informed consent was obtained. After birth, infants were echocardiographically assessed by a pediatric cardiologist to confirm the cardiac diagnosis. Infants were excluded from further participation if cardiac diagnosis could not be confirmed, if born before a gestational age of 36 weeks, or in case of major chromosomal, genetic or structural anomalies that became apparent after birth. This study was approved by the Medical Ethical Committee of the University Medical Center Groningen METc number: METc2014/083.

Neurological outcome

Neurological outcome was assessed by general movements (GMs) at two different moments. Preoperatively, at the age of 7 days (5–10 days), a video recording of 30–60 minutes was made. Postoperatively, at the age of 3 months, a video recording of approximately 10 minutes was made [34]. During the recordings, the infants wore a diaper or body to ensure visibility of movements. Video recordings during crying or sucking on a dummy were excluded from the analysis.

The GMs were scored independently by two different assessors (MJM and AFB) and one of them was unaware of the clinical condition of the patient (AFB). Both observers are certified as advanced scorers by the GM Trust. At the age of 7 days, the GMs were scored as either normal or abnormal. Abnormal GMs included poor repertoire, chaotic, and cramped synchronized movement patterns. Furthermore, we explored more detailed aspects of the motor repertoire reflected in a motor optimality score (MOS). At this age, the MOS ranges from 8 (poor) to 18 (optimal) and MOS <15 was considered to be abnormal. At the age of 3 months we assessed the presence and quality of fidgety movements (normal/abnormal/absent). Furthermore, we assessed the MOS which ranges from 5 (poor) to 28 (optimal) at this age and MOS <25 was considered to be abnormal [35–36].

Doppler flow patterns

During pregnancy, pulsatility indices of the middle cerebral artery (MCA-PI) and umbilical artery (UA-PI) were measured repeatedly by an experienced fetal medicine expert (CMB) and cerebroplacental ratio (CPR) was calculated. All Doppler parameters were converted into Z-scores to adjust for differences in gestational age at fetal examinations. For statistical purposes, the last available Doppler measurement before birth was used.

Near-infrared spectroscopy

After birth, cerebral oxygen saturation (rcSO2) was measured with the INVOS 5100c spectrometer (Medtronic, Dublin, Ireland) with neonatal sensors (Medtronic), placed on the frontoparietal side of the forehead. First, rcSO2 was measured daily for at least two consecutive and stable hours during the first 3 days after birth starting immediately after stabilization of the infant on the NICU. Preferably, the measurements were performed at the same time each day to avoid possible effects of diurnal variation. Second, rcSO2 was measured during every corrective/palliative surgical procedure within the first 3 months after birth. Third, rcSO2 was measured for 24 hours following each invasive cardiac procedure within the first 3 months after birth. Simultaneously with rcSO2 measurements, we measured preductal arterial oxygen saturation (SpO2) and calculated cerebral fractional tissue oxygen extraction (FTOE). For statistical purposes, we selected representative two-hour periods of stable rcSO2 measurements, preferably at the same time during the day, and calculated mean rcSO2 and FTOE for each of the first 3 days after birth. In addition, we calculated mean rcSO2 and FTOE during cardiac surgery and for 24 hours after cardiac surgery. Furthermore, we assessed the burden of hypoxia in two ways (percent of time <60% and percent of time <50%) and rcSO2 nadir during cardiac surgery.

Statistical analysis

For statistical analyses, we used SPSS version 23.0 (IBM Corp., Armonk, NY, USA) and for graphical display GraphPad Prism version 5 was used. Data are presented as either median (range) or number (percentage). First, we used descriptive statistics to visualize the association between fetal Doppler flow patterns, postnatal, intraoperative and postoperative rcSO2 and FTOE and short-term neurological outcome. Second, we used Spearman’s correlation coefficient or Mann-Whitney U test to assess the association between short-term neurological outcome and fetal Doppler flow patterns, rcSO2 and FTOE. Third, we categorized fetal Doppler flow patterns, postnatal rcSO2, intraoperative rcSO2 and postoperative rcSO2 as being either normal or abnormal and used Fisher’s exact test to assess the association between the number of abnormal values and short-term neurological outcome. Abnormal prenatal Doppler flow patterns were defined as Z-scores >1.0 or <-1.0. Abnormal rcSO2 was defined as values <60% or >90% [37–38]. The lower rcSO2 cut-off value was based on the hypoxia-ischemia threshold of 33–44% for functional impairment. As these values were measured with a sensor that measures approximately 10% lower than the sensors we used, we chose for 60% as the lower cut-off value [37]. The higher cut-off value was based on Verhagen et al. who found that values >90% were associated with poorer outcome [38]. A P-value <0.05 was considered significant.

Results

Patient characteristics

Initially, 45 fetuses with CHD were included between May 2014 and August 2016 (Fig 1). After birth, nine neonates were excluded, as they did not meet the inclusion criteria. Three infants were not admitted to the ICU, three infants were excluded due to chromosomal or genetic abnormalities (45XO, duplication chromosome 7 and Kabuki syndrome), two infants were excluded because of preterm birth and one fetus was stillborn. Gestational age at birth was 39.1 (36.6–40.3) weeks and birth weight was 3535 (2100–4120) grams. One infant had an Apgar score <6 at 5 minutes with a pH of the umbilical artery of 7.23. Shortly after birth, one infant presented with a brief period of persistent pulmonary hypertension of the neonate. Seven infants died; one because of massive myocardial infarction prior to surgery, two because of inoperable cardiac lesions, two because of severe brain injury after cardiopulmonary resuscitation, and two infants due to other (non-cardiac) reasons. Twenty-six infants (72%) underwent cardiac surgery during the study period. Median (range) number of interventions was 1 (1–3) and three infants (8%) between 2 and 27 days after birth. Patient characteristics are presented in Table 1 and detailed aspects of the included cardiac lesions are presented in S1 Table.

Fig 1. Flow chart inclusion and exclusion.

Fig 1

Open in a new tab

CHD, congenital heart disease; TOP, termination of pregnancy; IUFD, intrauterine fetal demise; NICU, neonatal intensive care unit. * Cardiac lesions that require birth at a congenital heart center.

Table 1. Patient characteristics.

N = 36
Gestational age at birth (weeks) 39.1 (36.6–40.3)
Birth weight (grams) 3535 (2100–4120)
Birth weight <10th percentile 6 (16)
Male 21 (58)
Type of CHD
    • TGA
    • HLHS
    • Pulmonary stenosis
    • Pulmonary atresia
    • Coarctation of the aorta
    • Tetralogy of Fallot
    • Common arterial trunk
    • Complex CHD
    • AVSD
    • Tricuspid dysplasia
    • DORV		 9 (25)
4 (11)
1 (3)
2 (6)
4 (11)
4 (11)
3 (8)
4 (11)
1 (3)
1 (3)
3 (8)
Apgar at 5 minutes 8 (5–10)
Mortality 7 (19)
MABP day 1 44 (37–51)
MABP day 2 47 (34–56)
MABP day 3 46 (42–54)
Respiratory support day 1 (n = 35)
    • None/low flow
    • CPAP
    • NIPPV
    • SIMV/SIPPV		 19 (54)
9 (26)
1 (3)
6 (17)
Respiratory support day 2 (n = 34)
    • None/low flow
    • CPAP
    • NIPPV
    • SIMV/SIPPV		 19 (56)
3 (9)
2 (6)
10 (29)
Respiratory support day 3 (n = 32)
    • None/low flow
    • CPAP
    • NIPPV
    • SIMV/SIPPV		 20 (63)
3 (9)
2 (6)
7 (22)
Medical treatment
Prostaglandin E1 day 1 (n = 35) 22 (63)
Prostaglandin E1 day 2 (n = 34) 22 (65)
Prostaglandin E1 day 3 (n = 32) 21 (66)
Sedatives day 1 (n = 35) 8 (23)
Sedatives day 2 (n = 34) 15 (44)
Sedatives day 3 (n = 32) 12 (38)
Placental insufficiency (pathology report) 4 (11)
Abnormality cerebral echocardiogram 7 (19)
ICU stay (days) 10 (4–90)
Age at surgery (days) 9 (2–27)
Open in a new tab

Data represent either median (range) or number (percentage). CHD, congenital heart disease; TGA, transposition of the great arteries; HLHS, hypoplastic left heart syndrome; AVSD, atrioventricular septal defect; DORV, double outlet right ventricle; MABP, mean arterial blood pressure; CPAP, continuous positive airway pressure; NIPPV, nasal intermittent positive pressure ventilation; SIMV, synchronized intermittent mandatory ventilation; SIPPV, synchronized intermittent positive pressure ventilation; ICU, intensive care unit.

Neurological outcome

Preoperatively, GMs were recorded in 25 infants. Fourteen infants (56%) had abnormal GMs. They all scored poor repertoire, none had chaotic or cramped synchronized movements. Motor optimality score was 13 (10–18). In eleven infants, GMs were not recorded due to scheduled surgery prior to the age of five days (n = 4), immobility due to sedation (n = 1), transfer to another hospital within five days after birth (n = 3) and mortality (n = 3).

At the age of three months, GMs were recorded in 29 infants. Two infants had absent fidgety movements and one had abnormal fidgety movements. Motor optimality score was 26 (11–28). Based on the cut-off point of <25, twelve infants (41%) had abnormal motor optimality scores. Reasons for missing recordings at this age were mortality before the age of three months (n = 6) and withdrawal from study participation (n = 1).

Twenty-one infants had GMs assessment at both ages. Of these infants, ten remained stable, three deteriorated and eight improved (Table 2). McNemar test confirmed that the trend of deterioration of the infants over time was not significant (P = 0.25). Two of the three infants with deteriorating neurological outcome had a complicated postoperative course. One infant had low cardiac output syndrome and the other infant developed a cardiac tamponade needing a re-intervention.

Table 2. The course of general movements in infants with CHD.

Infant GM 7 GM 3 Change Infant GM 7 GM 3 Change
1† x x na 19† A x na
2 x N na 20 N N =
3 A N ↑ 21 A A =
4† N x na 22 x A na
5 A N ↑ 23 A N ↑
6 A N ↑ 24 N N =
7 x A na 25† A x na
8† N x na 26† x x na
9 N A ↓ 27 A A =
10 N N = 28 x A na
11 A N ↑ 29 A N ↑
12 N N = 30 x x na
13 x A na 31 A N ↑
14 x N na 32 N N =
15 x N na 33 N A ↓
16 N N = 34 N A ↓
17 A A = 35 A A =
18 x A na 36 A N ↑
Open in a new tab

GM 7, preoperative general movements at the age of 7 days; GM 3, postoperative general movements at the age of 3 months; x, not recorded; N, normal assessment; A, abnormal assessment; na, not applicable; †, infant died before the age of 3 months.

Fetal cerebral vascular resistance and neonatal cerebral oxygen saturation

Prenatal Doppler flow patterns were assessed in all infants. Gestational age at the last fetal examination was 34.4 (21.1–39.1) weeks. In comparison with reference values of healthy fetuses, we found slightly lower MCA-PI (-0.19 (-3.94 to 2.59), P = 0.35) and CPR (-0.65 (-4.06 to 2.80), P = 0.01) and slightly higher UA-PI Z-scores (0.44 (-1.74 to 4.01), P = 0.02).

After birth, rcSO2 increased from 61% (32%-89%) to 70% (52%-91%) during the first 3 days after birth. On day 1, six neonates had rcSO2 values <50%, which could be explained by clinical conditions (restrictive foramen ovale, fetal-maternal transfusion or perinatal asphyxia). All neonates stabilized during the first 3 days and none of the neonates had rcSO2 values <50% on day 3 after birth. Twenty-six neonates (72%) had at least one cardiac surgical procedure within the first 3 months after birth. During surgical procedures, rcSO2 was lower in comparison with the first 3 days after birth (53% (36%-69%)). Median duration of surgery was 7.0 (1.5–12.3) hours. The median burden of hypoxia <60% and <50% was 68% (4%-100%) and 34% (0%-95%) of the recording time, respectively. The median rcSO2 nadir during surgery was 22% (15%-56%). Following cardiac surgery, rcSO2 increased to 61% (42%-78%).

Timing of occurrence of brain injury

Prenatal Doppler flow patterns strongly correlated with MOS at 3 months of age. Pulsatility index of the middle cerebral artery (rho 0.41, P = 0.04) and CPR (rho 0.50, P = 0.01) positively correlated with MOS, while UA-PI negatively correlated (rho -0.39, P = 0.04) with MOS at 3 months of age. There were no significant correlations between postnatal, intraoperative (mean, burden of hypoxia and nadir) and postoperative rcSO2 or FTOE and MOS at the age of 3 months.

Results were similar for abnormal and normal MOS (Fig 2 and S2 Table). Infants with abnormal MOS had lower MCA-PI (P = 0.02), higher UA-PI (P = 0.03) and lower CPR (P = 0.01) in comparison with infants with normal MOS at the age of 3 months. Cerebral oxygen saturation during the first 3 days after birth was lower in infants with abnormal MOS, however, this did not reach statistical significance. Both during and after surgical procedures rcSO2 (mean, burden of hypoxia and nadir) was similar in infants with normal and infants with abnormal MOS. In infants with abnormal MOS, FTOE tended to be higher during the first three days after birth, reaching statistical significance on day 2 (P = 0.04). During and after cardiac surgical procedures, there were no associations between FTOE and short-term neurological outcome. The number of interventions was also not associated with GMs at an age of 3months (P = 0.12).

Fig 2. Fetal Doppler flow patterns, postnatal rcSO2 and FTOE according to GMs assessment at the age of 3 months.

Fig 2

Open in a new tab

Data are shown in box-and-whisker plots. Circles represent outliers. N, normal general movements based on MOS ≥25; A, abnormal general movements based on MOS <25; MCA-PI, pulsatility index of the middle cerebral artery; UA-PI, pulsatility index of the umbilical artery; CPR, cerebroplacental ratio; rcSO2, regional cerebral oxygen saturation; FTOE, fractional tissue oxygen extraction.

Infants with a combination of abnormal prenatal and postnatal cerebral values were more likely to have abnormal MOS in comparison with infants that had no abnormal cerebral values or only at one of both periods (odds ratio = 9.33, P = 0.02).

Discussion

This is the first study assessing longitudinally the relationship between cerebral perfusion- or oxygenation parameters and short-term neurological outcome in infants with prenatally diagnosed CHD. The study demonstrates that prenatal Doppler flow patterns indicative of preferential brain perfusion are associated with poorer short-term neurological outcome in infants with CHD. Furthermore, it suggests that abnormal short-term neurological outcomes are likely the result of a cumulative effect of hypoxic-ischemic events during the prenatal period and early postnatal life. Infants with abnormal perfusion or oxygenation both prenatally as well as postnatally had a nine-fold increased risk of abnormal short-term neurological outcome in comparison with infants with no abnormal cerebral findings or abnormal cerebral findings only prenatally or postnatally.

Assessment of GMs is a widely accepted non-invasive method to determine the integrity of the central nervous system of the newborn [39]. At present, GMs are considered the best available method to assess short-term neurological outcome with a high sensitivity and specificity. Little is known about the quality of GMs in a CHD population. More is known on GMs in preterm born infants and, to a lesser extent, in term born infants [36,40–43]. The predictive value for neurological outcome of poor repertoire during the writhing period (around term age) is low [44]. However, absence of fidgety movements at an age of 3 months is strongly associated with adverse neurological outcome at school age [36,41]. Furthermore, abnormal MOS at an age of 3 months is also associated with motor impairments and minor neurological dysfunction at school age[40,42,43].

In our study, abnormal prenatal Doppler flow patterns indicative of preferential brain perfusion were associated with poorer short-term neurological outcome. Previous studies have reported contradictory results concerning the association between prenatal Doppler flow patterns and neurodevelopmental outcome in infants with CHD. Two studies found a negative association between MCA-PI and psychomotor developmental index evaluated by the Bayley scale of infant development II (BSID II) [7,45]. One study did not find any association between MCA-PI and neurodevelopmental outcome and another study found a positive correlation between MCA-PI and cognition measured by Bayley scale of infants and toddler development III (Bayley III) [5,46]. These contradictory findings may be explained by differences in study design (first vs. last Doppler measurement during pregnancy) and differences in cardiac lesions included in the study (different types of CHD with different circulatory and pathophysiological effects).

Our results indicate that Doppler patterns indicative for compensatory “brain sparing” mechanisms during fetal life actually suggest that oxygen delivery to the brain is insufficient to meet metabolic demands in fetuses with CHD. This may lead to impaired brain maturation, a finding that has been commonly reported in fetuses and neonates with CHD [10–15]. The preterm brain is likely to be more susceptible to hypoxic-ischemic events, explaining why fetuses with abnormal Doppler flow patterns are more prone to have abnormal short-term neurological outcomes [47].

While rcSO2 during the first 3 days was consistently lower and FTOE higher in infants with abnormal MOS at 3 months of age, we were unable to demonstrate a statistically significant association between preoperative cerebral oxygenation and developmental outcome. It might be that there is no association between preoperative oxygenation and short-term neurological outcome in infants with prenatally diagnosed CHD. We assessed neurological outcome at 3 months of age using the best available method at present, with a high sensitivity and specificity. We speculate that the brain may, at least transiently, be able to recover from hypoxic-ischemic events suffered immediately after birth. Brain development continues throughout childhood and involves not only the onset of new pathways and connections, but also elimination of others [48]. Due to the high plasticity of the young brain, previous abnormalities might disappear, at least transiently. It might also be that preoperative rcSO2 is associated with developmental outcome, but that our sample size was too small to reach statistical significance. Previous studies on the association between preoperative rcSO2 and neurodevelopmental outcome in infants with CHD, however, support our first explanation, as they were also unable to demonstrate a clear association between preoperative rcSO2 and neurodevelopmental outcome [49–50].

Cerebral oxygen saturation and FTOE during and after cardiac surgery were not associated with short-term neurological outcome. This is in line with previous literature[48–51]. Although some of these studies found an association between immediate preoperative, intraoperative or postoperative rcSO2 and various domains of neurodevelopmental outcome, rcSO2 was never a strong predictor of neurodevelopmental outcome [49–52]. Advanced surgical techniques and postoperative ICU care might prevent additional brain injury.

As we found that infants with abnormal perfusion or oxygenation both prenatally and postnatally had a nine-fold increased risk of having abnormal short-term neurological outcome, we suggest that there is a cumulative effect of hypoxic-ischemic events in infants with prenatally diagnosed CHD. This multiple-hit theory has been previously described in very preterm born infants [53]. Abnormal Doppler flow patterns before birth could have increased vulnerability of the brain to hypoxic-ischemic events after birth. Impaired brain maturation might be an important contributor to this vulnerability [11–16].

This study has several strengths and limitations. The longitudinal design from prenatal diagnosis until the age of 3 months is unique and important since infants with CH D are at risk of developing brain injury at various moments during early life. The observational design, however, implied that some of the values were missing, which might have induced selection bias. Other limitations were the relatively small sample size and the heterogeneity of the study population. The included types of CHD might have different effects on cerebral oxygenation and perfusion and they are associated with a different postnatal course (e.g. some infants required multiple surgeries during the first 3 months, while others did not require surgery). The infants with a more intense treatment course might have had less opportunity to develop certain age-appropriate skills. This could have influenced GMs at an age of 3 months. Nonetheless, our study population is a representative sample of an ICU and all included lesions have been associated with neurodevelopmental impairments later in life [1]. Furthermore, we did not have neuro-imaging data which could have confirmed brain injury or impaired brain maturation to support our vulnerability hypothesis in infants with abnormal GMs. In addition, we assessed short-term neurological outcome at only 3 months of age using GMs and MOS. The prognostic value of GMs and MOS is excellent for cerebral palsy and very good for mild motor abnormalities in preterm and healthy term infants. Less is known about the prognostic value of GMs and MOS in infants with CHD. Furthermore the prognostic value for cognitive deficits later on is less strong, which are a prominent finding in this population. Future studies should address these limitations and include enough patients to stratify for cardiac lesion. It is also crucial to extend neurodevelopmental testing to an older age in order to determine whether the associations we found persist later in infancy and childhood. Furthermore, future studies should address the cumulative effect of hypoxic-ischemic events, including multiple surgical procedures. This is also known as the multiple hit theory. We hope, with this study, to set the tone for these future larger (multicenter) longitudinal studies.

In conclusion, based on our findings we hypothesize that the prenatal period may play an important role in developmental outcome in infants with CHD that were admitted to the ICU immediately after birth. Additional research is needed to clarify the association between cerebral oxygenation during the first days after birth and neurological outcome in infants with CHD.

Supporting information

S1 Table. Type of CHD.

MA, mitral atresia; AA, aortic atresia.

(DOCX)

Click here for additional data file. (16.2KB, docx)
S2 Table. Fetal Doppler flow patterns, postnatal rcSO2 and FTOE according to GMs assessment at the age of three months.

Data are presented as median (range). MOS, motor optimality score; MCA-PI, pulsatility index of the middle cerebral artery; UA-PI, pulsatility index of the umbilical artery; CPR, cerebroplacental ratio; rcSO2, cerebral oxygen saturation; FTOE, cerebral fractional tissue oxygen extraction. * indicates P-value <0.05.

(DOCX)

Click here for additional data file. (16.2KB, docx)
S1 Data

(SAV)

Click here for additional data file. (22.6KB, sav)

Acknowledgments

This study was part of the research program of the Graduate School of Medical Sciences, Research Institutes BCN-BRAIN and GUIDE. We would like to thank S.J. Kuik, M.A. Hempenius, M van der Heide, A.J. Olthuis, B.M. Dotinga, E.A. Feitsma and nurses and other staff of the neonatal and pediatric intensive care unit and the division of pediatric cardiology for their help with the data collection.

Data Availability

All relevant data are within the paper and its Supporting Information files.

Funding Statement

M.J. Mebius was financially supported by a University of Groningen Junior Scientific Masterclass grant.

References

  • 1.Marino BS, Lipkin PH, Newburger JW, Peacock G, Gerdes M, Gaynor JW et al. ; American Heart Association Congenital Heart Defects Committee, Council on Cardiovascular Disease in the Young, Council on Cardiovascular Nursing, and Stroke Council. Neurodevelopmental outcomes in children with congenital heart disease: evaluation and management: a scientific statement from the American Heart Association. Circulation 2012;126:1143–1172. 10.1161/CIR.0b013e318265ee8a [DOI] [PubMed] [Google Scholar]
  • 2.Ringle ML, Wernovsky G. Functional, quality of life, and neurodevelopmental outcomes after congenital cardiac surgery. Semin Perinatol 2016;40:556–570. 10.1053/j.semperi.2016.09.008 [DOI] [PubMed] [Google Scholar]
  • 3.Apers S, Luyckx K, Moons P. Quality of life in adult congenital heart disease: what do we already know and what do we still need to know? Curr Cardiol Rep 2013;15:407–413 10.1007/s11886-013-0407-x [DOI] [PubMed] [Google Scholar]
  • 4.Zeng S, Zhou J, Peng Q, Tian L, Xu G, Zhao Y et al. Assessment by three-dimensional power Doppler ultrasound of cerebral blood flow perfusion in fetuses with congenital heart disease. Ultrasound Obstet Gynecol 2015;45:649–656 10.1002/uog.14798 [DOI] [PubMed] [Google Scholar]
  • 5.Mebius MJ, Kooi EMW, Bilardo CM, Bos AF. Brain Injury and Neurodevelopmental Outcome in Congenital Heart Disease: A Systematic Review. Pediatrics 2017;140:10.1542. [DOI] [PubMed] [Google Scholar]
  • 6.Masoller N, Martinez JM, Gomez O, Bennasar M, Crispi F, Sanz-Cortés M et al. Evidence of second-trimester changes in head biometry and brain perfusion in fetuses with congenital heart disease. Ultrasound Obstet Gynecol 2014;44:182–187. 10.1002/uog.13373 [DOI] [PubMed] [Google Scholar]
  • 7.Hahn E, Szwast A, Cnota J 2nd, Levine JC, Fifer CG, Jaeggi E et al. Association between fetal growth, cerebral blood flow and neurodevelopmental outcome in univentricular fetuses. Ultrasound Obstet Gynecol 2016;47:460–465. 10.1002/uog.14881 [DOI] [PubMed] [Google Scholar]
  • 8.Zeng S, Zhou QC, Zhou JW, Li M, Long C, Peng QH. Volume of intracranial structures on three-dimensional ultrasound in fetuses with congenital heart disease. Ultrasound Obstet Gynecol 2015;46:174–18. 10.1002/uog.14677 [DOI] [PubMed] [Google Scholar]
  • 9.Yamamoto Y, Khoo NS, Brooks PA, Savard W, Hirose A, Hornberger LK. Severe left heart obstruction with retrograde arch flow influences fetal cerebral and placental blood flow. Ultrasound Obstet Gynecol 2013;42:294–299. 10.1002/uog.12448 [DOI] [PubMed] [Google Scholar]
  • 10.Arduini M, Rosati P, Caforio L, Guariglia L, Clerici G, Di Renzo GC et al. Cerebral blood flow autoregulation and congenital heart disease: possible causes of abnormal prenatal neurologic development. J Matern Fetal Neonatal Med 2011;24:1208–1211. 10.3109/14767058.2010.547961 [DOI] [PubMed] [Google Scholar]
  • 11.Al Nafisi B, van Amerom JF, Forsey J, Jaeggi E, Grosse-Wortmann L, Yoo SJ et al. Fetal circulation in left-sided congenital heart disease measured by cardiovascular magnetic resonance: a case-control study. J Cardiovasc Magn Reson 2013;15:65–429. 10.1186/1532-429X-15-65 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12.Clouchoux C, du Plessis AJ, Bouyssi-Kobar M, Tworetzky W, McElhinney DB, Brown DW et al. Delayed cortical development in fetuses with complex congenital heart disease. Cereb Cortex 2013;23:2932–2943. 10.1093/cercor/bhs281 [DOI] [PubMed] [Google Scholar]
  • 13.Masoller N, Sanz-CorteS M, Crispi F, Gómez O, Bennasar M, Egaña-Ugrinovic G et al. Mid-gestation brain Doppler and head biometry in fetuses with congenital heart disease predict abnormal brain development at birth. Ultrasound Obstet Gynecol 2016;47:65–73. 10.1002/uog.14919 [DOI] [PubMed] [Google Scholar]
  • 14.Limperopoulos C, Tworetzky W, McElhinney DB, Newburger JW, Brown DW, Robertson RL Jr et al. Brain volume and metabolism in fetuses with congenital heart disease: evaluation with quantitative magnetic resonance imaging and spectroscopy. Circulation 2010;121:26–33. 10.1161/CIRCULATIONAHA.109.865568 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15.Brossard-Racine M, du Plessis A, Vezina G, Robertson R, Donofrio M, Tworetzky W et al. Brain Injury in Neonates with Complex Congenital Heart Disease: What Is the Predictive Value of MRI in the Fetal Period? AJNR Am J Neuroradiol 2016;37:1338–1346. 10.3174/ajnr.A4716 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16.Brossard-Racine M, du Plessis AJ, Vezina G, Robertson R, Bulas D, Evangelou IE et al. Prevalence and spectrum of in utero structural brain abnormalities in fetuses with complex congenital heart disease. AJNR Am J Neuroradiol 2014;35:1593–1599. 10.3174/ajnr.A3903 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17.von Rhein M, Buchmann A, Hagmann C, Dave H, Bernet V, Scheer O et al. Severe Congenital Heart Defects Are Associated with Global Reduction of Neonatal Brain Volumes. J Pediatr 2015;167:1259–63.e1. 10.1016/j.jpeds.2015.07.006 [DOI] [PubMed] [Google Scholar]
  • 18.Ortinau C, Inder T, Lambeth J, Wallendorf M, Finucane K, Beca J. Congenital heart disease affects cerebral size but not brain growth. Pediatr Cardiol 2012;33:1138–1146. 10.1007/s00246-012-0269-9 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 19.Licht DJ, Shera DM, Clancy RR, Wernovsky G, Montenegro LM, Nicolson SC et al. Brain maturation is delayed in infants with complex congenital heart defects. J Thorac Cardiovasc Surg 2009;137:529–36. 10.1016/j.jtcvs.2008.10.025 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 20.Sethi V, Tabbutt S, Dimitropoulos, Harris KC, Chau V, Poskitt K et al. Single-ventricle anatomy predicts delayed microstructural brain development. Pediatr Res 2013;73:661–667. 10.1038/pr.2013.29 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 21.Park IS, Yoon SY, Min JY, Kim YH, Ko JK, Kim KS et al. Metabolic alterations and neurodevelopmental outcome of infants with transposition of the great arteries. Pediatr Cardiol 2006;27:569–576. 10.1007/s00246-004-0730-5 [DOI] [PubMed] [Google Scholar]
  • 22.Mebius MJ, van der Laan ME, Verhagen EA, Roofthooft MT, Bos AF, Kooi EM. Cerebral oxygen saturation during the first 72h after birth in infants diagnosed antenatally with congenital heart disease. Early Hum Dev 2016;103:199–203. 10.1016/j.earlhumdev.2016.10.001 [DOI] [PubMed] [Google Scholar]
  • 23.Kurth CD, Steven JL, Montenegro LM, Watzman HM, Gaynor JW, Spray TL et al. Cerebral oxygen saturation before congenital heart surgery. Ann Thorac Surg 2001;72:187–192. 10.1016/s0003-4975(01)02632-7 [DOI] [PubMed] [Google Scholar]
  • 24.Limperopoulos C, Majnemer A, Shevell MI, Rosenblatt B, Rohlicek C, Tchervenkov C. Neurodevelopmental status of newborns and infants with congenital heart defects before and after open heart surgery. J Pediatr 2000;137:638–645. 10.1067/mpd.2000.109152 [DOI] [PubMed] [Google Scholar]
  • 25.Ter Horst HJ, Mud M, Roofthooft MT, Bos AF. Amplitude integrated electroencephalographic activity in infants with congenital heart disease before surgery. Early Hum Dev 2010;86:759–764. 10.1016/j.earlhumdev.2010.08.028 [DOI] [PubMed] [Google Scholar]
  • 26.Mulkey SB, Yap VL, Bai S, Ramakrishnaiah RH, Glasier CM, Bornemeier RA et al. Amplitude-integrated EEG in newborns with critical congenital heart disease predicts preoperative brain magnetic resonance imaging findings. Pediatr Neurol 2015;52:599–605. 10.1016/j.pediatrneurol.2015.02.026 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 27.Mulkey SB, Ou X, Ramakrishnaiah RH, Glasier CM, Swearingen CJ, Melguizo MS et al. White matter injury in newborns with congenital heart disease: a diffusion tensor imaging study. Pediatr Neurol 2014;51:377–383. 10.1016/j.pediatrneurol.2014.04.008 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 28.Miller SP, McQuillen PS, Vigneron DB, Glidden DV, Barkovich AJ, Ferriero DM et al. Preoperative brain injury in newborns with transposition of the great arteries. Ann Thorac Surg 2004;77:1698–1706. 10.1016/j.athoracsur.2003.10.084 [DOI] [PubMed] [Google Scholar]
  • 29.McQuillen PS, Barkovich AJ, Hamrick SE, Perez M, Ward P, Glidden DV et al. Temporal and anatomic risk profile of brain injury with neonatal repair of congenital heart defects. Stroke 2007;38:736–741. 10.1161/01.STR.0000247941.41234.90 [DOI] [PubMed] [Google Scholar]
  • 30.Salameh A, Dhein S, Dahnert I, Klein N. Neuroprotective Strategies during Cardiac Surgery with Cardiopulmonary Bypass. Int J Mol Sci 2016;17:E1945 10.3390/ijms17111945 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 31.Burkhardt BE, Rucker G, Stiller B. Prophylactic milrinone for the prevention of low cardiac output syndrome and mortality in children undergoing surgery for congenital heart disease. Cochrane Database Syst Rev 2015:CD009515 10.1002/14651858.CD009515.pub2 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 32.Algra SO, Haas F, Poskitt KJ, Groenendaal F, Schouten AN, Jansen NJ et al. Minimizing the risk of preoperative brain injury in neonates with aortic arch obstruction. J Pediatr 2014;165:1116–1122.e3. 10.1016/j.jpeds.2014.08.066 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 33.Beca J, Gunn JK, Coleman L, Hope A, Reed PW, Hunt RW et al. New white matter brain injury after infant heart surgery is associated with diagnostic group and the use of circulatory arrest. Circulation 2013. March;127:971–979. 10.1161/CIRCULATIONAHA.112.001089 [DOI] [PubMed] [Google Scholar]
  • 34.Einspieler C, Prechtl HF, Ferrari F, Cioni G, Bos AF. The qualitative assessment of general movements in preterm, term and young infants—review of the methodology. Early Hum Dev 1997;50:47–60. 10.1016/s0378-3782(97)00092-3 [DOI] [PubMed] [Google Scholar]
  • 35.Bruggink JL, Einspieler C, Butcher PR, Stremmelaar EF, Prechtl HF, Bos AF. Quantitative aspects of the early motor repertoire in preterm infants: do they predict minor neurological dysfunction at school age? Early Hum Dev 2009;85:25–36. 10.1016/j.earlhumdev.2008.05.010 [DOI] [PubMed] [Google Scholar]
  • 36.Bruggink JL, Einspieler C, Butcher PR, Van Braeckel KN, Prechtl HF, Bos AF. The quality of the early motor repertoire in preterm infants predicts minor neurologic dysfunction at school age. J Pediatr 2008;153:32–39. 10.1016/j.jpeds.2007.12.047 [DOI] [PubMed] [Google Scholar]
  • 37.Kurth CD, Levy WJ, McCann J. Near-infrared spectroscopy cerebral oxygen saturation thresholds for hypoxia-ischemia in piglets. J Cereb Blood Flow Metab 2002; 22:335–341. 10.1097/00004647-200203000-00011 [DOI] [PubMed] [Google Scholar]
  • 38.Verhagen EA, Van Braeckel KN, van der Veere CN, Groen H, Dijk PH, Hulzebos CV et al. Cerebral oxygenation is associated with neurodevelopmental outcome of preterm children at age 2 to 3 years. Dev Med Child Neurol 2015;57:449–455. 10.1111/dmcn.12622 [DOI] [PubMed] [Google Scholar]
  • 39.Einspieler C, Prechtl HF. Prechtl's assessment of general movements: a diagnostic tool for the functional assessment of the young nervous system. Ment Retard Dev Disabil Res Rev 2005;11:61–67. 10.1002/mrdd.20051 [DOI] [PubMed] [Google Scholar]
  • 40.Bruggink JL, van Spronsen FJ, Wijnberg-Williams BJ, Bos AF. Pilot use of the early motor repertoire in infants with inborn errors of metabolism: outcomes in early and middle childhood. Early Hum Dev 2009;85:461–465. 10.1016/j.earlhumdev.2009.04.002 [DOI] [PubMed] [Google Scholar]
  • 41.Hitzert MM, Roze E, Van Braeckel KN, Bos AF. Motor development in 3-month-old healthy term-born infants is associated with cognitive and behavioural outcomes at early school age. Dev Med Child Neurol 2014;56:869–876. 10.1111/dmcn.12468 [DOI] [PubMed] [Google Scholar]
  • 42.Hadders-Algra M, Mavinkurve-Groothuis AM, Groen SE, Stremmelaar EF, Martijn A, Butcher PR. Quality of general movements and the development of minor neurological dysfunction at toddler and school age. Clin Rehabil 2004;18:287–299. 10.1191/0269215504cr730oa [DOI] [PubMed] [Google Scholar]
  • 43.Bos AF, Martijn A, Okken A, Prechtl HF. Quality of general movements in preterm infants with transient periventricular echodensities. Acta Paediatr 1998;87:328–335. 10.1080/08035259850157417 [DOI] [PubMed] [Google Scholar]
  • 44.Nakajima Y, Einspieler C, Marschik PB, Bos AF, Prechtl HF. Does a detailed assessment of poor repertoire general movements help to identify those infants who will develop normally? Early Hum Dev 2006;82:53–59. 10.1016/j.earlhumdev.2005.07.010 [DOI] [PubMed] [Google Scholar]
  • 45.Williams IA, Fifer C, Jaeggi E, Levine JC, Michelfelder EC, Szwast AL. The association of fetal cerebrovascular resistance with early neurodevelopment in single ventricle congenital heart disease. Am Heart J 2013;165:544–550.e1. 10.1016/j.ahj.2012.11.013 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 46.Williams IA, Tarullo AR, Grieve PG, Wilpers A, Vignola EF, Myers MM et al. Fetal cerebrovascular resistance and neonatal EEG predict 18-month neurodevelopmental outcome in infants with congenital heart disease. Ultrasound Obstet Gynecol 2012;40:304–309. 10.1002/uog.11144 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 47.Volpe JJ. Brain injury in premature infants: a complex amalgam of destructive and developmental disturbances. Lancet Neurol 2009;8:110–124. 10.1016/S1474-4422(08)70294-1 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 48.Stiles J, Jernigan TL. The basics of brain development. Neuropsychol Rev 2010;20:327–348. 10.1007/s11065-010-9148-4 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 49.Sood ED, Benzaquen JS, Davies RR, Woodford E, Pizarro C. Predictive value of perioperative near-infrared spectroscopy for neurodevelopmental outcomes after cardiac surgery in infancy. J Thorac Cardiovasc Surg 2013;145:438–445.e1 10.1016/j.jtcvs.2012.10.033 [DOI] [PubMed] [Google Scholar]
  • 50.Toet MC, Flinterman A, Laar I, Vries JW, Bennink GB, Uiterwaal CS et al. Cerebral oxygen saturation and electrical brain activity before, during, and up to 36 hours after arterial switch procedure in neonates without pre-existing brain damage: its relationship to neurodevelopmental outcome. Exp Brain Res 2005;165:343–350 10.1007/s00221-005-2300-3 [DOI] [PubMed] [Google Scholar]
  • 51.Simons J, Sood ED, Derby CD, Pizarro C. Predictive value of near-infrared spectroscopy on neurodevelopmental outcome after surgery for congenital heart disease in infancy. J Thorac Cardiovasc Surg 2012;143:118–125. 10.1016/j.jtcvs.2011.09.007 [DOI] [PubMed] [Google Scholar]
  • 52.Kussman BD, Wypij D, Laussen PC, Soul JS, Bellinger DC, DiNardo JA et al. Relationship of intraoperative cerebral oxygen saturation to neurodevelopmental outcome and brain magnetic resonance imaging at 1 year of age in infants undergoing biventricular repair. Circulation 2010;122:245–254. 10.1161/CIRCULATIONAHA.109.902338 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 53.Leviton A, Fichorova RN, O'Shea TM, Kuban K, Paneth N, Dammann O et al. Two-hit model of brain damage in the very preterm newborn: small for gestational age and postnatal systemic inflammation. Pediatr Res 2013;73:362–370 10.1038/pr.2012.188 [DOI] [PMC free article] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

S1 Table. Type of CHD.

MA, mitral atresia; AA, aortic atresia.

(DOCX)

Click here for additional data file. (16.2KB, docx)
S2 Table. Fetal Doppler flow patterns, postnatal rcSO2 and FTOE according to GMs assessment at the age of three months.

Data are presented as median (range). MOS, motor optimality score; MCA-PI, pulsatility index of the middle cerebral artery; UA-PI, pulsatility index of the umbilical artery; CPR, cerebroplacental ratio; rcSO2, cerebral oxygen saturation; FTOE, cerebral fractional tissue oxygen extraction. * indicates P-value <0.05.

(DOCX)

Click here for additional data file. (16.2KB, docx)
S1 Data

(SAV)

Click here for additional data file. (22.6KB, sav)

Data Availability Statement

All relevant data are within the paper and its Supporting Information files.

Articles from PLoS ONE are provided here courtesy of PLOS

RESOURCES